Validating AI Search in GMP: A Qualification Strategy for RAG

AI search is often presented as a low-risk layer because it “only retrieves documents.” In GMP environments, that assumption is unsafe. A Retrieval-Augmented Generation (RAG) system influences decisions, shapes investigations, and can alter how QA, Validation, and operations teams interpret approved procedures. If the system is used to answer questions on SOPs, validation protocols, deviations, or regulatory expectations, it requires a defined qualification strategy grounded in intended use, risk, and evidence. For mid-size pharma manufacturers and CDMOs in DACH, the practical question is not whether RAG is innovative. It is whether AI search can be shown to be fit for use under GAMP 5 Second Edition, EU Annex 11, 21 CFR Part 11 where applicable, and the quality system expectations of ICH Q7 and ICH Q10.

Why AI search must be qualified in GMP

In regulated operations, “search” is not a neutral utility if personnel rely on it to locate, summarize, and interpret controlled content. A RAG assistant may retrieve the right SOP, but if it ranks obsolete documents too highly, fails to find an exception process, or generates an answer that overstates what the source says, the compliance impact is real. This is especially relevant in CDMO environments where quality agreements, client-specific procedures, and site SOPs coexist.

Under EU Annex 11, regulated companies must validate computerized systems for their intended use and maintain data integrity, security, and record controls. GAMP 5 Second Edition reinforces a risk-based approach and puts greater emphasis on critical thinking, product and process understanding, service-provider oversight, and modern software delivery models. ICH Q10 expects a pharmaceutical quality system that manages knowledge and change effectively. If AI search becomes part of how regulated knowledge is accessed, qualification is the mechanism that demonstrates control.

Practical rule: if QA, QC, Validation, Engineering, or Manufacturing may use AI search to support GMP decisions, treat it as a GxP-relevant computerized function and qualify accordingly.

Define intended use before discussing model performance

The most common validation mistake is starting with benchmark scores instead of intended use. In GMP, the qualification strategy should begin with a precise statement of what the system is allowed to do, for whom, on which content, and with which controls.

• Permitted use: answer questions using approved internal procedures, validation documents, and regulatory references.
• Restricted use: no autonomous approval, no generation of original GMP records, no replacement of trained judgment.
• User groups: QA, CSV, Engineering, Production support, site SMEs.
• Content scope: effective SOPs, current templates, approved validation plans, selected regulations and guidance.
• Output constraints: answers must include source citations and document metadata; if confidence or retrieval quality is insufficient, the system must defer.

This intended-use statement should drive the entire lifecycle: supplier assessment, user requirements, configuration, testing, training, access control, and periodic review. Without it, teams cannot determine what “fit for use” means.

Qualification focus for RAG is different from classic search

Traditional document search is typically qualified for indexing, permissions, and retrieval. RAG introduces additional failure modes because retrieval and generation are coupled. A qualification strategy therefore needs to assess not only whether documents can be found, but whether the right source fragments are selected, whether the answer remains faithful to those fragments, and whether users can verify the basis of the response.

For GMP use, QA and Validation teams should examine at least five control layers:

• Content governance: only approved, in-scope, current documents are indexed; obsolete versions are clearly segregated or excluded.
• Metadata integrity: document ID, version, effective date, owner, status, and site applicability are preserved.
• Retrieval behavior: the system returns relevant passages consistently for representative compliance questions.
• Generation constraints: answers are grounded in retrieved content and do not fabricate unsupported requirements.
• User control and traceability: users can inspect citations, open source documents, and understand when the system did not find enough evidence.

This is where many generic AI search tools fail. They may perform well in broad enterprise knowledge tasks but lack controls for document status, GMP context, and traceable answers.

A practical qualification strategy for GMP RAG

For most pharma and CDMO teams, the most effective approach is a risk-based qualification package aligned with standard CSV deliverables, adapted to the RAG architecture.

1. Supplier and service assessment

Assess the AI provider as you would any software supplier supporting GxP processes. Review security, change management, backup, incident handling, access controls, and release practices. Under GAMP 5 Second Edition, supplier leverage is appropriate, but only if justified. For cloud-based AI services, understand hosting locations, subprocessors, and data handling obligations relevant to EU operations.

2. Risk assessment

Perform a formal risk assessment tied to patient risk, product quality risk, and data integrity risk. Typical hazards include retrieval of superseded SOPs, omission of client-specific requirements, inaccurate summaries, permission leakage across departments, and overreliance by users during deviation or CAPA activities. Classify risks and define technical and procedural controls.

3. User requirements and functional specifications

Requirements should be specific enough to test. Examples:

• The system shall restrict indexing to approved repositories and document types.
• The system shall display source citations for every answer.
• The system shall preserve user access permissions from the source system.
• The system shall identify document version and effective date in the response context.
• The system shall log user queries and system responses in accordance with company policy.
• The system shall indicate when no sufficient source basis is available.

4. Installation and configuration qualification

IQ/OQ for RAG should cover connectors, indexing pipelines, embedding models, retrieval settings, prompt templates, access roles, audit logging, and environment segregation. If multiple sites or business units are involved, verify tenant and permission boundaries carefully. In DACH CDMOs, where client confidentiality is central, this point deserves particular scrutiny.

5. Performance qualification with GMP-realistic test cases

PQ is where the system must prove fitness for intended use. Avoid generic AI tests. Use site-specific, role-specific scenarios drawn from real work:

• Find the approved hold-time procedure for intermediates at Site A.
• Explain whether an MES user-role change requires requalification under the local change procedure.
• Identify the deviation escalation timeline defined in the current SOP and show the source section.
• Compare a client quality agreement requirement with the site SOP for environmental monitoring review.

For each test, define expected source documents, expected answer boundaries, and acceptance criteria. Assess not just correctness, but citation quality, consistency, and safe failure behavior.

What good acceptance criteria look like

AI qualification often becomes weak because acceptance criteria are vague. “The answer should be accurate” is not testable enough. More robust criteria for RAG include:

• Retrieval relevance: required source documents appear in top-ranked results for defined test cases.
• Groundedness: the answer contains no material claim not supported by retrieved text.
• Traceability: each answer includes direct citations to document and section level where feasible.
• Version control: the system preferentially uses effective versions and excludes obsolete content from standard answers.
• Access control: users cannot retrieve or infer restricted content.
• Fallback behavior: when retrieval is weak or conflicting, the system asks for clarification or advises users to consult the document owner.

These criteria are especially relevant under EU Annex 11 expectations for accuracy, reliability, and access control, and under 21 CFR Part 11 where electronic records and system controls intersect with regulated use.

Document management remains part of validation

Many AI search failures are actually document-control failures. If the source repository contains duplicate SOPs, missing metadata, uncontrolled PDFs, or delayed archival of obsolete versions, the RAG layer will amplify those weaknesses. Qualification should therefore include verification of the document ingestion and refresh process:

• How often are repositories synchronized?
• What happens when a document changes status from draft to effective to obsolete?
• How are scanned PDFs and poor OCR handled?
• How are multilingual documents managed across German and English content?
• How are client-specific and site-specific procedures segregated?

For DACH organizations, bilingual or multilingual content is a recurring challenge. A qualified AI search tool must show that retrieval remains reliable across German and English queries without distorting regulatory meaning.

Operational controls after release

Qualification is not the end state. Under ICH Q10, knowledge management and continual improvement require ongoing oversight. Once released, AI search should be subject to procedures for incident management, change control, periodic review, and user training.

• Change control: assess changes to models, prompts, chunking strategy, connectors, and source repositories for validation impact.
• Periodic review: trend failed queries, user complaints, retrieval misses, and citation issues.
• Training: teach users what the system is for, what it is not for, and how to verify cited sources.
• Monitoring: review whether usage aligns with intended use and whether departments are attempting to extend it into uncontrolled workflows.

This ongoing control model also aligns with the broader governance expectations emerging under the EU AI Act. While not every RAG use case in pharma will fall into the same legal category, regulated companies should already be establishing documented oversight, risk controls, and human review for AI-enabled systems used in quality processes.

What inspectors and auditors will want to see

When an inspector or client auditor asks how AI search is controlled, the strongest answer is not a technical demo. It is a coherent validation story supported by evidence:

• documented intended use and boundaries
• risk assessment linked to GMP impact
• requirements and specifications for retrieval, citations, and access control
• executed IQ/OQ/PQ with realistic GMP scenarios
• supplier qualification and service oversight
• procedures for change control, periodic review, and training

That is what turns AI search from an interesting pilot into a defendable GMP system.

Validating RAG in GMP is not about proving that a language model is “smart.” It is about proving that AI search is controlled, traceable, and reliable enough for its intended compliance role. Teams that qualify retrieval, source integrity, and user verification explicitly are in a far stronger position than teams that validate only the interface.

See how ComplianceRAG handles validating AI search in GMP for pharma and CDMO teams: See it in action →